| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |